Company Quick10K Filing
CNA Financial
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-02-09
10-Q 2020-09-30 Filed 2020-11-02
10-Q 2020-06-30 Filed 2020-08-03
10-Q 2020-03-31 Filed 2020-05-04
10-K 2019-12-31 Filed 2020-02-11
10-Q 2019-09-30 Filed 2019-10-28
10-Q 2019-06-30 Filed 2019-08-05
10-Q 2019-03-31 Filed 2019-04-29
10-K 2018-12-31 Filed 2019-02-13
10-Q 2018-09-30 Filed 2018-11-05
10-Q 2018-06-30 Filed 2018-07-30
10-Q 2018-03-31 Filed 2018-04-30
10-K 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-10-30
10-Q 2017-06-30 Filed 2017-07-31
10-Q 2017-03-31 Filed 2017-05-01
10-K 2016-12-31 Filed 2017-02-15
10-Q 2016-09-30 Filed 2016-10-31
10-Q 2016-06-30 Filed 2016-08-01
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-17
10-Q 2015-09-30 Filed 2015-11-03
10-Q 2015-06-30 Filed 2015-08-04
10-Q 2015-03-31 Filed 2015-05-05
10-K 2014-12-31 Filed 2015-02-23
10-Q 2014-09-30 Filed 2014-11-04
10-Q 2014-06-30 Filed 2014-08-04
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-19
10-Q 2013-09-30 Filed 2013-10-29
10-Q 2013-06-30 Filed 2013-07-30
10-K 2012-12-31 Filed 2013-02-21
10-Q 2012-09-30 Filed 2012-10-30
10-Q 2012-06-30 Filed 2012-07-31
10-Q 2012-03-31 Filed 2012-05-01
10-K 2011-12-31 Filed 2012-02-21
10-Q 2011-09-30 Filed 2011-11-01
10-Q 2011-06-30 Filed 2011-08-02
10-Q 2011-03-31 Filed 2011-05-03
10-K 2010-12-31 Filed 2011-02-22
10-Q 2010-09-30 Filed 2010-11-02
10-Q 2010-06-30 Filed 2010-08-03
10-Q 2010-03-31 Filed 2010-05-03
10-K 2009-12-31 Filed 2010-02-23
8-K 2021-02-08 Earnings, Exhibits
8-K 2020-12-30 Enter Agreement, Regulation FD, Exhibits
8-K 2020-11-02
8-K 2020-08-11
8-K 2020-08-10
8-K 2020-08-03
8-K 2020-07-15
8-K 2020-05-04
8-K 2020-04-29
8-K 2020-03-06
8-K 2020-02-25
8-K 2020-02-10
8-K 2019-12-19
8-K 2019-10-28
8-K 2019-08-05
8-K 2019-05-01
8-K 2019-04-29
8-K 2019-04-24
8-K 2019-02-11
8-K 2018-12-03
8-K 2018-11-05
8-K 2018-09-05
8-K 2018-08-01
8-K 2018-07-30
8-K 2018-04-30
8-K 2018-04-26
8-K 2018-04-25
8-K 2018-04-06
8-K 2018-02-12

CNA Financial Financials

CNA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Bioquest Corp (BQST)
30DC (TDCH)
BriaCell Therapeutics Corp. (BCTXW)
DD3 Acquisition Corp. II (DDMXW)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
8i Acquisition 2 Corp. (LAX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash84847559100129156123121185195206204247190201145236387242289290271299225283355282288310310223271340
Accounts Receivable
Inventory
PP&E300324309307310317326323327334304293289287295298317320343263276287310324336325326346347332324314302293
Assets55,77455,84455,17956,00756,49958,61258,52258,72757,56757,18757,19458,22459,43755,73155,56655,46555,02254,81255,04755,50256,90656,85955,23355,20156,20556,58256,56757,64957,85857,25957,15258,47759,96360,450
Accounts Payable
Long-Term Debt2,6482,6382,6082,6092,6092,5702,5702,5712,5712,5592,5603,1073,1073,1082,5592,5602,5602,5612,5622,7082,7082,7092,7102,7102,7112,8572,8582,7092,7092,6802,6802,6812,6782,678
Liabilities44,02543,88843,62244,02644,28545,95246,20846,32245,62345,03444,54345,64246,36342,69742,77243,02842,78842,54743,29144,03245,02044,66443,26443,50844,17744,41344,32346,22446,44345,74945,93547,02247,87648,327
Stockholders' Equity11,60211,80811,55711,98112,21412,66012,31412,40511,94412,15312,65112,58213,07413,03412,79412,43712,23412,26511,75611,47011,88612,19511,96911,69312,02812,16912,24411,42511,41511,51011,21711,45512,08712,123
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,1982,1752,2592,4012,2462,4662,4342,5032,4932,5042,6132,4632,4402,4112,3782,3522,3272,1532,2692,1952,3482,4332,3902,3302,3662,3982,4482,5352,5742,6222,4032,6952,6102,685
Cost of Revenue
Gross Profit
R&D
SG&A
Tax4749481146493-271138210378781038454802655-91-97913276839843187556066776420
Net Income13275190250166221-925019427222113267213198233138178-7066209343241260272144223291270336-84342278107
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating40188931230637525719137828316841946039394446505342334279507296282233379360218136514287227466
Cash Investing-314-843-287-223-237-187-161-310-209-354-380-353169526-439-341-118-9-158-437-242354-243-329-206489-50-359289-56-293
Cash Financing-84-56-42-41-112-44-56-71-64210-47-68-614-603-67-69-68-469-69-67-68-609-684-82-781-74-134-665-123-99